Medical management of benign prostatic hyperplasia with androgen suppression
- 1 January 1990
- journal article
- research article
- Published by Wiley in The Prostate
- Vol. 17 (S3), 49-59
- https://doi.org/10.1002/pros.2990170506
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Hormonal effects of an orally active 4‐azasteroid inhibitor of 5α‐reductase in humansThe Prostate, 1989
- The Effect of Nafarelin Acetate, a Luteinizing-Hormone–Releasing Hormone Agonist, on Benign Prostatic HyperplasiaNew England Journal of Medicine, 1987
- Effect of a new 5α-reductase inhibitor on size, histologic characteristics, and androgen concentrations of the canine prostateThe Prostate, 1982
- The effects of flutamide on total DHT and nuclear DHT levels in the human prostateThe Prostate, 1981
- Effect of megestrol acetate on uroflow rates in patients with benign prostatic hypertrophyUrology, 1979
- Megestrol acetate in treatment of benign prostatic hypertrophyUrology, 1975
- Steroid 5α-Reductase Deficiency in Man: An Inherited Form of Male PseudohermaphroditismScience, 1974
- QUANTITATIVE STUDIES OF PROSTATIC SECRETIONThe Journal of Experimental Medicine, 1940
- THE QUESTION OF CASTRATION FOR ENLARGED PROSTATEAnnals of Surgery, 1896
- THE RESULTS OF DOUBLE CASTRATION IN HYPERTROPHY OF THE PROSTATEAnnals of Surgery, 1895